Coronary Sinus Reducer for Recurrent Chest Pain

"Reducing Heart Disease Risk: Understanding the Benefits of Coronary Sinus Reducer"

Senior Interventional Cardiologist

Senior Interventional Cardiologist

"Reducing Heart Disease Risk: Understanding the Benefits of Coronary Sinus Reducer"

Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei…

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an…

Introduction The development of a safe and effective vaccine against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is critical for ensuring worldwide public health, as well as potentially ending the coronavirus disease-2019 (COVID-19) pandemic. Four vaccine candidates have finished or are currently…

Tricuspid regurgitation in the cath lab: six heart-team rules on RV function, pulmonary pressure, TRI-SCORE, T-TEER vs TTVR, and when the answer is no.

Stent thrombosis in the cath lab: 6 rules to classify, image, correct the cause, escalate P2Y12 therapy and plan DAPT, with PARIS, PESTO and PLATO data.

Ostial left main calcium PCI: my seven cath-lab decisions on IVUS, IVL versus rotablation, test inflation, sizing, EBU 3.5 guide and aorto-ostial stenting.
Dr A M Thirugnanam is a senior interventional cardiologist based in Hyderabad, India, known for complex coronary intervention — left main disease, chronic total occlusions and haemodynamically supported angioplasty — and for two procedures presented at international conferences as world-first…
Books & Courses | Dr AM Thirugnanam | Senior Interventional Cardiologist 🏆 CRT 2026 Washington DC — Highest Graded Abstract Award · Oral Presenter: CTO & Left Main Stenting · Late-Breaking Trial: Tirzepatide & TAVR · View All Awards →…

Understanding the Treatment of Non Obstructive Coronary Artery Disease With Myocardial Bridging The treatment of non obstructive coronary artery disease with myocardial bridging has become a growing focus in modern cardiology. Patients can experience chest pain, breathlessness, or fatigue even…

Air Embolism in the Cath Lab: Coronary, Pulmonary and Cerebral Complications Practical guide for cardiologists to recognise, manage, and prevent air embolism in the cath lab – focusing on coronary, pulmonary and cerebral circulation. This article is written for interventional…

Introduction: Infective endocarditis (IE) is a serious and potentially life-threatening condition characterized by the infection of the inner lining of the heart chambers and heart valves. This condition can affect both native heart valves, which a person is born with,…

Dr. Am Thirugnanam is a cardiologist with over 20 years of experience. He specializes in preventive cardiology, cardiac imaging, and interventional cardiology. He is board certified in Internal Medicine and Cardiovascular Disease. He is affiliated with several hospitals in the area and is committed to providing quality care to his patients.
You must be logged in to post a comment.